The VistaCare treatment episode ends as soon as the granulation is deemed sufficient with a satisfactory wound bed for it to be covered by dressings, autologous grafts, a dermal substitute or a flap.
During the inflammatory stage VistaCare plays a major role in cleansing thanks to a high level of hygrometry. This will facilitate the debridement of the wound by softening the necrosis and fibrin by promoting the action of proteases and growth factors and by accelerating the cell multiplication process.
During the budding/granulation stage, oxygen management promotes angiogenic action, procollagen synthesis and keratinocyte migration. The VistaCare treatment ends as soon as the granulation is deemed sufficient with a satisfactory wound bed for it to be covered by dressings, autologous grafts or a dermal substitute. Studies will need to be conducted to confirm the interest of an extension of VistaCare to increase the efficiency of engraftment.
In the epithelialization stage, the drop in hygrometry follows the needs of the wound, promoting cell differentiation.